Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
Go back to Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan| (NASDAQ: MDCX) | Delayed: 0.45 -0.01 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $ | |||
| Open | $0.46 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 2,875,785 | |||||
| (NASDAQ: MDCX) | Delayed: 0.45 -0.01 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $ | |||
| Open | $0.46 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 2,875,785 | |||||

